Trust Point’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Trust Point's AQST Position: Q3 2026 in Review
Trust Point opened a new position in Aquestive Therapeutics (AQST) in Q3 2026: 31,048 shares worth $144K. The stake represents 0.01% of the portfolio and ranks #506 among its holdings. This is a return to the name: Trust Point previously reported a position in AQST as recently as Q1 2026.
Trust Point first reported a position in AQST in Q4 2023 and has held it in 10 quarters since. The position peaked at $155K in Q4 2025. 142 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- Trust Point held 31,048 shares of Aquestive Therapeutics worth $144K as of Q3 2026.
- Aquestive Therapeutics was a new Trust Point position in Q3 2026.
- Aquestive Therapeutics made up 0.01% of Trust Point's portfolio in Q3 2026, its #506 holding.
- Trust Point first reported a position in Aquestive Therapeutics in Q4 2023 and has held it in 10 quarters since.
- Trust Point's Aquestive Therapeutics position peaked at $155K in Q4 2025.
- 142 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.